|1.||Dauvilliers, Yves: 9 articles (09/2014 - 12/2004)|
|2.||Black, Jed: 8 articles (01/2015 - 11/2004)|
|3.||Donjacour, Claire E H M: 7 articles (10/2015 - 03/2011)|
|4.||Nishino, Seiji: 7 articles (10/2011 - 06/2005)|
|5.||Hornfeldt, Carl S: 7 articles (12/2010 - 06/2002)|
|6.||Pijl, Hanno: 6 articles (10/2015 - 03/2011)|
|7.||Overeem, Sebastiaan: 6 articles (10/2015 - 03/2011)|
|8.||Arnulf, Isabelle: 6 articles (06/2014 - 11/2004)|
|9.||Lammers, Gert Jan: 6 articles (01/2014 - 01/2010)|
|10.||Smith, Stephen W: 6 articles (12/2011 - 01/2004)|
09/01/2009 - "The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy."
02/01/2002 - "Sodium oxybate significantly improved symptoms in patients with narcolepsy and was well tolerated."
10/15/2005 - "When combined with its previously demonstrated anticataplectic effects, the results of the current study indicate sodium oxybate is the first drug to demonstrate efficacy for the 2 major symptoms of narcolepsy."
10/15/2005 - "A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy."
03/01/2008 - "Sodium oxybate appears to be an effective and well-tolerated treatment for all the key symptoms of the two forms of narcolepsy."
09/01/2005 - "In the largest study of its kind, sodium oxybate was highly effective for the treatment of cataplexy. "
03/01/2006 - "Sodium oxybate is safe and effective for the treatment of cataplexy. "
03/01/2006 - "In placebo-controlled trials, sodium oxybate demonstrated efficacy in reducing the number of cataplexy attacks. "
03/01/2006 - "Study selection included human trials evaluating safety and efficacy of sodium oxybate for the treatment of cataplexy. "
03/01/2004 - "This controlled trial provides evidence supporting the long-term efficacy of sodium oxybate for the treatment of cataplexy. "
01/01/1967 - "[On the mode of action of sodium gamma-hydroxybutyrate employed as protection against hyperoxic convulsions]."
07/15/2014 - "The patient was later weaned off sodium oxybate, and a repeat study did not show any such electrographic seizures. "
07/15/2014 - "An overnight full montage electroencephalography (EEG) study revealed numerous frontally predominant rhythmic 1.5-2 Hz sharp waves and spike-wave activity during stage N2 and N3 sleep at the peak dose time for sodium oxybate, resembling atypical absence-like electrographic seizures. "
07/15/2014 - "We present the first reported human case of absence-like electrographic seizure associated with sodium oxybate."
06/01/1993 - "Epileptogenic spikes and seizures but not high voltage spindles are induced by local frontal cortical application of gamma-hydroxybutyrate."
05/01/1994 - "Treatment with gamma-hydroxybutyrate (GHB), a compound that we have previously demonstrated to be highly effective in preventing ischemia-reperfusion injury, significantly reduced both the microvascular stasis and leukocyte accumulation in all three vascular beds. "
05/01/2004 - "gamma-hydroxybutyrate (GHB) has been reported to exert protective effects against ischemia-reperfusion injury to various organs. "
10/01/1992 - "We have previously shown that gamma-hydroxybutyrate (GHB) protects the small intestine against ischemia/reperfusion injury. "
05/01/2004 - "gamma-hydroxybutyrate protects the liver from warm ischemia-reperfusion injury in rat."
01/01/1997 - "Gamma-hydroxybutyrate (GHB), an endogenous regulator of energy metabolism, showed beneficial effects on experimental intestinal ischemia/reperfusion injury and liver graft function. "
|5.||Brain Ischemia (Cerebral Ischemia)
05/26/2000 - "In conclusion, these results indicate that gamma-hydroxybutyrate provides significant protection against both histological and behavioral consequences of transient global cerebral ischemia in rats."
01/01/2008 - "Gamma-hydroxybutyrate accelerates functional recovery after focal cerebral ischemia."
02/06/2004 - "Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat."
05/26/2000 - "Neuroprotective effect of gamma-hydroxybutyrate in transient global cerebral ischemia in the rat."
09/01/1992 - "[Effects of gamma-hydroxybutyrate on monoamine metabolism and protein synthesis after transient global cerebral ischemia]."
|1.||Sodium Oxybate (gamma Hydroxybutyrate)
|3.||Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
|5.||gamma-Aminobutyric Acid (GABA)
|6.||Hypnotics and Sedatives (Sedatives)
|7.||Antidepressive Agents (Antidepressants)
|9.||Ethanol (Ethyl Alcohol)
|10.||4-Butyrolactone (gamma Butyrolactone)
|1.||Drug Therapy (Chemotherapy)